SearchDictionaryMobileLogin

G K Khuller Selected Research

Tuberculosis

02/2008Novel chemotherapy for tuberculosis: chemotherapeutic potential of econazole- and moxifloxacin-loaded PLG nanoparticles.
02/2007Lung and blood mononuclear cell responses of tuberculosis patients to mycobacterial proteins.
10/2005Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis.
06/2005Peripheral blood and pleural fluid mononuclear cell responses to low-molecular-mass secretory polypeptides of Mycobacterium tuberculosis in human models of immunity to tuberculosis.
05/2005Human immune recognition-based multicomponent subunit vaccines against tuberculosis.
12/2004Chemotherapeutic efficacy of poly (DL-lactide-co-glycolide) nanoparticle encapsulated antitubercular drugs at sub-therapeutic dose against experimental tuberculosis.
10/2004Lectin-functionalized poly (lactide-co-glycolide) nanoparticles as oral/aerosolized antitubercular drug carriers for treatment of tuberculosis.
04/2004Liposome-based antitubercular drug therapy in a guinea pig model of tuberculosis.
12/2003Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis.
09/2003Chemotherapeutic potential of orally administered poly(lactide-co-glycolide) microparticles containing isoniazid, rifampin, and pyrazinamide against experimental tuberculosis.
04/2003Alginate-based oral drug delivery system for tuberculosis: pharmacokinetics and therapeutic effects.
01/2003Nanoparticle encapsulated antitubercular drugs as a potential oral drug delivery system against murine tuberculosis.
10/2002Chemotherapeutic activity against murine tuberculosis of once weekly administered drugs (isoniazid and rifampicin) encapsulated in liposomes.
02/2001Therapeutic potential of human neutrophil peptide 1 against experimental tuberculosis.
02/2001Sustained release of isoniazid from a single injectable dose of poly (DL-lactide-co-glycolide) microparticles as a therapeutic approach towards tuberculosis.

Articles by Research Topic

Disease

15Tuberculosis
02/2008 - 02/2001
4Infection
07/2004 - 01/2001

Drug/Important Bio-Agent (IBA)

5Carbon MonoxideIBA
12/2004 - 01/2001
5poly(lactide) (polylactide)IBA
12/2004 - 01/2001
4Isoniazid (Ftivazide)FDA LinkGeneric
09/2003 - 02/2001
3Antitubercular AgentsIBA
12/2004 - 01/2001
3Liposomes (Liposome)IBA
04/2004 - 10/2002
3Rifampin (Rifampicin)FDA LinkGeneric
09/2003 - 06/2001
2Drug CarriersIBA
10/2005 - 10/2004
2alginic acid (sodium alginate)IBA
10/2005 - 04/2003
2Polyglactin 910IBA
10/2004 - 09/2003
1moxifloxacin (Avelox)FDA Link
02/2008
1EconazoleFDA LinkGeneric
02/2008
1Proteins (Proteins, Gene)IBA
02/2007
1PeptidesIBA
06/2005
1Subunit VaccinesIBA
05/2005
1PolymersIBA
07/2004
1PyrazinamideFDA LinkGeneric
09/2003
1human neutrophil peptide 1IBA
02/2001

Therapy/Procedure

3Drug Therapy (Chemotherapy)
02/2008 - 06/2001